Pharmaceutical Preparations · DE · CIK 1660334
Verrica Pharmaceuticals develops and commercializes clinician-administered therapies for dermatologic diseases, including skin cancers
Comparable business profile · signals at a glance
In the 90 days to Nov 25, 2025: 5 insiders bought $18.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Manning Paul BDirector,TenPercentOwner | Buy | 2,750,762 | $4.24 | $11.7M |
| Nov 25, 2025 | Manning Paul BDirector,TenPercentOwner | Buy | 1,375,380 | $4.24 | $5.8M |
| Nov 25, 2025 | Rieger JaysonCEO and President | Buy | 94,311 | $4.24 | $400K |
| Nov 25, 2025 | Zawitz DavidChief Operating Officer | Buy | 10,000 | $4.24 | $42K |
| Nov 25, 2025 | Kirby John J.Interim CFO | Buy | 3,536 | $4.24 | $15K |
| Nov 25, 2025 | Rosenberg Noah L.CMO | Buy | 2,357 | $4.24 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.